{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:24:41Z","timestamp":1793690681672,"version":"4.5.1"},"reference-count":30,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Germ line DDX41 mutations (DDX41mut) are identified in \u223c5% of myeloid malignancies with an excess of blasts, representing a distinct myelodysplastic syndrome (MDS)\/acute myeloid leukemia (AML) entity. The disease is associated with better outcomes than DDX41 wild-type (DDX41WT) cases, but patients who do not undergo allogeneic hematopoietic stem cell transplantation (HSCT) may experience late relapse. Because of the recent identification of DDX41mut, data on the post-HSCT outcomes remain limited. In this study, we report the HSCT outcomes of 83 patients with DDX41mut MDS\/AML. With a median follow-up of 4.4 years, the 2-year leukemia-free survival (LFS) was 68.6% (95% confidence interval [CI], 57.1-77.6) and the 2-year nonrelapse mortality (NRM) was 21.1% (95% CI, 12.9-30.6). We then assessed the impact of DDX41mut using a pair match analysis performed on patients who underwent a transplantation in AML clinical trials. No significant differences were observed between patients with DDX41mut and those with DDX41WT in terms of LFS at 2 years (hazard ratio, 1.06; 95% CI, 0.59-1.90; P = .84), overall survival, NRM, relapse, or graft-versus-host disease incidence. The cumulative incidence of relapse for DDX41mut showed a trend toward a lower relapse rate during the first year then higher after 1 year. Given the familial nature of the disease, we specifically examined patients who relapsed after HSCT with a related donor and identified 7 cases of DDX41mut donor cell leukemia. In this study, HSCT in patients with DDX41mut AML was not associated with an increased risk for toxicity. However, we observed a potential for later relapse, which could potentially be mitigated by selecting related donors based on DDX41 status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017084","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:08:43Z","timestamp":1757444923000},"page":"6314-6325","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Allogeneic hematopoietic stem cell transplantation in patients with germ line\n                    <i>DDX41<\/i>\n                    mutated myeloid malignancies"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-5939","authenticated-orcid":false,"given":"Michael","family":"Loschi","sequence":"first","affiliation":[{"name":"1Department of Hematology, University Hospital of Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-6612","authenticated-orcid":false,"given":"Marie-Charlotte","family":"Villy","sequence":"additional","affiliation":[{"name":"2Department of Oncogenetics, Saint-Louis Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Emmanuel","family":"Galimard","sequence":"additional","affiliation":[{"name":"3European Society for Blood and Marrow Transplantation Statistical Department, Saint-Antoine Hospital, Sorbonne University, Assistance Publique-H\u00f4pitaux de Paris, INSERM UMRs 938, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Mathilde","family":"Auboiroux","sequence":"additional","affiliation":[{"name":"4Department of Hematology, University Hospital of Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-4830","authenticated-orcid":false,"given":"Nathalie","family":"Gachard","sequence":"additional","affiliation":[{"name":"5Hematology Laboratory, University Hospital of Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-512X","authenticated-orcid":false,"given":"Alexandre","family":"Perani","sequence":"additional","affiliation":[{"name":"6Department of Medical Genetics, University Hospital of Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-4572","authenticated-orcid":false,"given":"Matthieu","family":"Duchmann","sequence":"additional","affiliation":[{"name":"7Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-5427","authenticated-orcid":false,"given":"Laetitia","family":"Largeaud","sequence":"additional","affiliation":[{"name":"8Hematology Laboratory, University Hospital of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Nguyen","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Pitie-Salpetriere Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-1556","authenticated-orcid":false,"given":"Flore","family":"Sicre de Fontbrune","sequence":"additional","affiliation":[{"name":"10Department of Hematology and Transplantation, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-9876","authenticated-orcid":false,"given":"Marie","family":"Robin","sequence":"additional","affiliation":[{"name":"10Department of Hematology and Transplantation, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-8782","authenticated-orcid":false,"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Centre Hospitalo-Universitaire de Lille, Universit\u00e9 de Lille, INSERM U1286, INFINITE, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Daguindau","sequence":"additional","affiliation":[{"name":"12Department of Hematology, University Hospital of Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-2252","authenticated-orcid":false,"given":"Sylvain","family":"Chantepie","sequence":"additional","affiliation":[{"name":"13Hematology Department, University Hospital of Caen, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Charbonnier","sequence":"additional","affiliation":[{"name":"14Department of Hematology, University Hospital of Amiens, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Lebon","sequence":"additional","affiliation":[{"name":"14Department of Hematology, University Hospital of Amiens, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-8683","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Maury","sequence":"additional","affiliation":[{"name":"15Hematology Department, Henri Mondor Hospital, Assistance Publique-H\u00f4pitaux de Paris, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Labussiere-Wallet","sequence":"additional","affiliation":[{"name":"16Department of Hematology, University Hospital of Lyon Sud, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-6198","authenticated-orcid":false,"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[{"name":"17Department of Hematology, University Hospital of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[{"name":"18Department of Hematology, University Hospital of Bordeaux Haut-Leveque, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Castilla-Llorente","sequence":"additional","affiliation":[{"name":"19Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cluzeau","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Hospital of Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-8766","authenticated-orcid":false,"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[{"name":"20Department of Hematology, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"D\u2019aveni","sequence":"additional","affiliation":[{"name":"21Department of Hematology, University Hospital of Nancy, Vandoeuvre les Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-8310","authenticated-orcid":false,"given":"Raynier","family":"Devillier","sequence":"additional","affiliation":[{"name":"22Department of Hematology, Paoli Calmettes Institute, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Maillard","sequence":"additional","affiliation":[{"name":"23Department of Hematology, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Benachour","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Hospital of Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[{"name":"20Department of Hematology, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-4525","authenticated-orcid":false,"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[{"name":"17Department of Hematology, University Hospital of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pigneux","sequence":"additional","affiliation":[{"name":"18Department of Hematology, University Hospital of Bordeaux Haut-Leveque, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-092X","authenticated-orcid":false,"given":"Emmanuelle","family":"Clappier","sequence":"additional","affiliation":[{"name":"7Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-0753","authenticated-orcid":false,"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[{"name":"24Department of Hematology, University Hospital of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-1022","authenticated-orcid":false,"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Centre Hospitalo-Universitaire de Lille, Universit\u00e9 de Lille, INSERM U1286, INFINITE, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Turlure","sequence":"additional","affiliation":[{"name":"4Department of Hematology, University Hospital of Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[{"name":"10Department of Hematology and Transplantation, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"S\u00e9bert","sequence":"additional","affiliation":[{"name":"20Department of Hematology, Saint-Louis Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"7","key":"2025122308361173800_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"17","key":"2025122308361173800_bib2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41 mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"S\u00e9bert","year":"2019","journal-title":"Blood"},{"issue":"5","key":"2025122308361173800_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"4","key":"2025122308361173800_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41375-024-02180-3","article-title":"Clinical impact of genetic alterations including germline DDX41 mutations in MDS\/low-blast count AML patients treated with azacitidine-based regimens","volume":"38","author":"S\u00e9bert","year":"2024","journal-title":"Leukemia"},{"issue":"7","key":"2025122308361173800_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.2021015328","article-title":"Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study","volume":"140","author":"Duployez","year":"2022","journal-title":"Blood"},{"issue":"11","key":"2025122308361173800_bib6","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/ajh.27070","article-title":"Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants","volume":"98","author":"Bataller","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"2025122308361173800_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.27138","article-title":"Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients","volume":"99","author":"Gangat","year":"2024","journal-title":"Am J Hematol"},{"issue":"7","key":"2025122308361173800_bib8","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"12","key":"2025122308361173800_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"26","key":"2025122308361173800_bib10","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/blood.2024026925","article-title":"Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML","volume":"144","author":"Lachowiez","year":"2024","journal-title":"Blood"},{"issue":"21","key":"2025122308361173800_bib11","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.2024025409","article-title":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","volume":"144","author":"D\u00f6hner","year":"2024","journal-title":"Blood"},{"issue":"24","key":"2025122308361173800_bib12","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2025122308361173800_bib13","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","article-title":"Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature","volume":"22","author":"Barbaro","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"2025122308361173800_bib14","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1016\/S2352-3026(23)00265-X","article-title":"Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT","volume":"10","author":"Gurnari","year":"2023","journal-title":"Lancet Haematol"},{"issue":"9","key":"2025122308361173800_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2017.05.022","article-title":"Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT","volume":"23","author":"Dietz","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2025122308361173800_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2004-04-1652","article-title":"Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2025122308361173800_bib17","first-page":"255","article-title":"Donor-derived malignancy and transplantation morbidity: risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Williams","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"4","key":"2025122308361173800_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/bloodadvances.2022008172","article-title":"Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies","volume":"7","author":"Saygin","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"2025122308361173800_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"2025122308361173800_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.18675","article-title":"Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group","volume":"201","author":"Speight","year":"2023","journal-title":"Br J Haematol"},{"issue":"1","key":"2025122308361173800_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2991\/chi.d.191207.001","article-title":"Summary of scientific and statistical methods, study endpoints and definitions for observational and registry-based studies in hematopoietic cell transplantation","volume":"2","author":"Kanate","year":"2020","journal-title":"Clin Hematol Int"},{"issue":"1","key":"2025122308361173800_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2025122308361173800_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"2025122308361173800_bib24","unstructured":"The R Foundation\n          . What is R?. Accessed 2 September 2024. https:\/\/www.r-project.org\/about.html."},{"issue":"4","key":"2025122308361173800_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2025122308361173800_bib26","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41409-022-01776-6","article-title":"Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia","volume":"57","author":"Baranwal","year":"2022","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"2025122308361173800_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41375-024-02152-7","article-title":"Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation","volume":"38","author":"Kambara","year":"2024","journal-title":"Leukemia"},{"issue":"2","key":"2025122308361173800_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2016.310","article-title":"Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation","volume":"31","author":"Berger","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"2025122308361173800_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/leu.2017.44","article-title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"2025122308361173800_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bjh.18682","article-title":"Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)","volume":"201","author":"Clark","year":"2023","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/24\/6314\/2474238\/blooda_adv-2025-017084-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/24\/6314\/2474238\/blooda_adv-2025-017084-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:36:22Z","timestamp":1766496982000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/24\/6314\/547196\/Allogeneic-hematopoietic-stem-cell-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":30,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025,12,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017084","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,23]]},"published":{"date-parts":[[2025,12,10]]}}}